This research study aims to improve the treatment of Peritoneal Carcinomatosis (PC), a condition where cancer spreads within the abdomen. Patients with PC often experience significant pain and nutritional problems. Currently, there isn't a standard treatment approach, and doctors use different combinations of chemotherapy, surgery, and methods to deliver chemotherapy directly into the abdomen (intra-peritoneal or "IP" chemotherapy). The study will compare two IP chemotherapy methods: HIPEC and PIPAC. HIPEC involves circulating heated chemotherapy through the abdomen during surgery, while PIPAC delivers chemotherapy as a pressurized aerosol during a laparoscopic procedure. Both methods aim to achieve the same goal, but they haven't been directly compared to see which is safer, more tolerable, more effective, and provides better value.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Heated intra-peritoneal chemotherapy (HIPEC) Adverse Events
Timeframe: 150 days from Day #1 visit
Heated intra-peritoneal chemotherapy (HIPEC) Surgical Complications
Timeframe: 150 days from Day #1 visit
Heated intra-peritoneal chemotherapy (HIPEC) Adverse Events
Timeframe: 150 days from Day #1 visit
Heated intra-peritoneal chemotherapy (HIPEC) Surgical Complications
Timeframe: 150 days from Day #1 visit
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Adverse Events
Timeframe: 150 days from Day #1 visit
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Adverse Events
Timeframe: 150 days from Day #1 visit
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Surgical Complications
Timeframe: 150 days from Day #1 visit
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Surgical Complications
Timeframe: 150 days from Day #1 visit
Heated intra-peritoneal chemotherapy (HIPEC) Tolerability
Timeframe: 150 days from Day #1 visit
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Tolerability
Timeframe: 150 days from Day #1 visit
Heated intra-peritoneal chemotherapy (HIPEC) Tolerability
Timeframe: 150 days from Day #1 visit
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Tolerability
Timeframe: 150 days from Day #1 visit
Heated intra-peritoneal chemotherapy (HIPEC) Tolerability
Timeframe: 150 days from Day #1 visit
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Tolerability
Timeframe: 150 days from Day #1 visit